ATR

AptarGroup, Inc.

AptarGroup, Inc. is a solution provider of packaging delivery solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets.

AptarGroup, Inc. (ATR) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B); its weakest is Growth (D+). The rating has held at C+ for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.6 / 5.0
C+
Value
B-
Factor Score 2.9 / 5.0
Growth
D+
Factor Score 1.7 / 5.0
Profitability
B
Factor Score 3.3 / 5.0
Momentum
B
Factor Score 3.3 / 5.0
Revisions
C-
Factor Score 2.0 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 34.2
EV / EBITDA 12.9
Rev Growth YoY 6.0%
Gross Margin 35.8%
Price Return 3M 9.0%
Price Return 12M 22.9%
Catalyst Signal +0.10
Market Cap $9.1B
TTM Revenue $4.0B
Price / Sales 2.3
ROE 9.8%

Historical Factor Score Progression

Held C+ for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-16 B- (2.9) D+ (1.7) B (3.3) B (3.3) C- (2.0) C+ (2.6)
2026-11-09 B- (2.9) D+ (1.7) B (3.3) B- (3.1) C- (2.0) C+ (2.6)
2026-11-05 B- (3.0) D+ (1.7) B (3.3) B- (2.9) C- (2.0) C+ (2.6)
2026-11-03 B- (3.0) D+ (1.7) B (3.3) C+ (2.8) C- (2.0) C+ (2.6)
2026-11-02 B- (3.0) D+ (1.7) B (3.3) C+ (2.7) C- (2.0) C+ (2.5)
Page 1 of 6